GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Archived. This submission is more than a year old. Votes and new comments are closed, and some of the advice in it may have been superseded — check the community wiki for the current version.
3k
c/trialwatch·posted 1 year ago by u/hamza_zielinski

am I the only one who found SELECT harder than the injections

Press Release Cold Box ×9 Sourced ×2 Clean Column ×2

Trying to settle this properly because the thread from last year went in circles.

The claim: FLOW matters. The counter-claim: it is measurement error. Both sides have been asserting it confidently for about 18 months without either producing anything.

What would actually settle it is 25 people measuring the same thing the same way. I have started; my numbers are below. They lean one way but not strongly enough for me to declare victory.

If you have data, post the data. If you have an opinion, flair it as an opinion.

3,473 up / 477 down88% upvoted14 commentsid yduyxc19 Dec 2024

14 comments

9 in this archive, depth 3

best — the order this archive was captured in

u/milos_vanhecke536 points·1 year ago

Disagree but this is the good kind of wrong — it is specific enough to be checked.

replysharereportpermalink
u/hamza_zielinskiOP253 points·1 year ago

SELECT reported a SURPASS hazard ratio but the absolute event rate is what changes clinical practice.

replysharereportpermalink
u/nhs_waitlist_nUK-23 points·1 year ago

the 7 week readout is different from the 6 week readout

replysharereportpermalink
u/annika_fonseca1 point·1 year ago

Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.

replysharereportpermalink
u/hamza_zielinskiOP1 point·1 year ago

SURMOUNT-4 discontinuation arm showed regain. That is the reality of a chronic disease treatment, not a failure.

replysharereportpermalink
u/marit_laurent197 points·1 year ago
this should be in the wiki
replysharereportpermalink
u/trialwatch_theoMOD104 points·1 year ago

Removed a chain here. The rule is one line long and it is not negotiable.

replysharereportpermalink
u/hamza_zielinskiOP65 points·1 year ago

STEP 1 readout: 98.6% mean weight loss, absolute numbers matter. Spread around that mean is enormous.

replysharereportpermalink
load more comments (1) →
Permalinked branches
Deep branches get their own page so a single reply chain can be linked and read on its own.
About c/trialwatch

Clinical trial reading group. New readouts, protocol amendments, endpoint definitions, dropout handling, and the difference between a press release and a publication. Absolute risk reduction and number-needed-to-treat are house dialect here.

34kmembers
95submissions
Nov 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/trialwatch rules
  1. Press-release-only posts must be flaired Press Release until a publication exists.
  2. Give the trial name, phase, n, and primary endpoint in the body.
  3. Relative risk reduction alone is not a result. Show the absolute numbers.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.